Project Grant HT9425261E269
Award Date 7/1/26
Completion Date 6/30/30
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Logan, UT 84322, USA
Similar Awards
- Federal Grant Award Summary The University of Utah received a $1,560,609 Project Grant from the Defense Health Agency under the Military Health Services Research (MHSR) Program (CFDA 12.007), effective September 1, 2025 through August 31, 2027. The award supports the TELE-MC Trial, which investigates the use of telehealth technology to expand access to physical therapy services and improve musculoskeletal care delivery within the Military Health System. This research directly supports the...
- Federal Grant Award Summary The University of Utah received a $695,255 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026, through July 31, 2029. The award funds research examining "The Value of Hypertension Control to Prevent Dementia and Enhance Readiness: Generating Evidence from DoD-VHA Data, Patient Preferences and Health Economics." The project will generate evidence-based research...
- Federal Grant Award Summary The University of Utah received a $1.39M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026 through June 30, 2029. The award funds research addressing exposure-induced lung injury and interventions to prevent early lung cancer progression. This three-year project aligns with the DHA's mission to transform healthcare for service members and the American public through...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, a Project Grant of $2.34 million under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 29, 2029. The award supports a randomized controlled trial (RCT) examining the efficacy of the Man Therapy platform in reducing problematic anger among military service members,...
- Federal Grant Award Summary The University of Utah received a $369,872 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, with an ultimate completion date of August 31, 2027. The award supports research on "Temporal Coding of the Human Auditory Nerve," a biomedical research initiative designed to advance understanding of auditory nerve function and contribute to innovations...
- Federal Grant Award Summary Colorado State University received a $320,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), with an award date of August 15, 2025, and an expected completion date of August 14, 2027. The project, titled "Overlooked No More: The Impact of the Menstrual Cycle on Neuromuscular Function in Women with Multiple Sclerosis," will be conducted at the university's Fort Collins, Colorado...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $2.41M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds research into cognitive rehabilitation interventions for the treatment of anger in veterans with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Research activities will be conducted...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $3.15 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with completion targeted for September 29, 2029. This clinical research award supports a randomized controlled trial investigating the efficacy of noninvasive brain stimulation combined with written exposure therapy as a treatment...
- Federal Grant Award Summary The University of Colorado-Denver received a $1.4 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026 through June 30, 2029. The award supports research focused on enhancing LAT (Linker for Activation of T cells) activity in chimeric antigen receptor (CAR) T cell therapies for Ewing sarcoma treatment. This research initiative represents the DHA's investment in...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $2.52 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded July 1, 2025, with a completion date of June 30, 2029. The award funds development and clinical evaluation of an artificial intelligence (AI)-facilitated, web-based training program for Written Exposure Therapy (WET)—an evidence-based treatment for...